NCT02146196

Brief Summary

Robotic assisted gait therapy with the Lokomat® as a new method for rehabilitation in advanced heart failure and after cardiac surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable heart-failure

Timeline
Completed

Started Feb 2014

Shorter than P25 for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 11, 2014

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 23, 2014

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

October 30, 2014

Status Verified

October 1, 2014

Enrollment Period

9 months

First QC Date

May 11, 2014

Last Update Submit

October 29, 2014

Conditions

Keywords

Heart failurerobotic assisted gait therapy

Outcome Measures

Primary Outcomes (8)

  • Deep sternal wound infections

    Occurence of deep sternal wound infections due to training, only in patients after cardiac surgery

    12 weeks after hospital discharge

  • Changes in VO2 (maximal oxygen uptak in ml/(kg*min))

    Change in maximal oxygen uptake during spiroergometry due to training, only in heart failure patients

    After four weeks robot-assisted training with the Lokomat®

  • Changes in BNP

    Change in brain natriuretic peptide due to training, measured in mg/ml. Only in heart failure patients.

    After four weeks robot-assisted training with the Lokomat®

  • Changes in strength measurement of the musculus quadriceps

    isometric strength of the musculus quadriceps measured in kilopond

    After four weeks robotic assisted training with the Lokomat®. In the postcardiotomy group after one week robot-assisted training

  • Changes in CRP (C- reactive protein)

    Change in C- reactive protein, due to training, measured in mg/ml. Only in heart failure patients.

    After four weeks robot-assisted training with the Lokomat®

  • Changes in IL 6 (interleukin 6)

    Change in interleukin 6(measured in mg/ml), due to training. Only in heart failure patients.

    After four weeks robot-assisted training with the Lokomat®

  • Changes in SF 36

    Questionaire (SF 36- short form 36 of health survey) to assess changes in quality of life due to the training. Only in heart failure patients

    After four weeks robot-assisted training with the Lokomat®

  • Changes in walking distance (in meters) in 6 minute walk test (MWT)

    6 minute walk test to assess changes in walking distance after training period, only in patients after cardiac surgery

    After one week robot-assisted training with the Lokomat®

Study Arms (2)

Heart failure, robotic assisted training

EXPERIMENTAL

4 weeks robotic assisted training with the Lokomat®

Device: 4 weeks robotic assisted training with the Lokomat®

Post cardiac surgery

EXPERIMENTAL

One week robotic assisted gait training with the Lokomat®

Device: One week robotic assisted gait training with the Lokomat®

Interventions

During a prespecified time period (4weeks) a three times weekly robotic assisted gait training during 30-45 minutes. Strength training, interval training and endurance training are possible.

Heart failure, robotic assisted training

During a prespecified time period (1week) a three times weekly robotic assisted gait training during 10-40 minutes. Strength training, interval training and endurance training are possible

Post cardiac surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Heart failure patients:
  • stable heart failure (over 3 months, NYHA 2, NYHA 3)
  • Left ventricular ejection fraction less than 45% postoperative patients:
  • possibility to walk at least 50m on the ground floor

You may not qualify if:

  • weight \>100kg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich

Zurich, Canton of Zurich, 8091, Switzerland

RECRUITING

Related Publications (2)

  • Schoenrath F, Markendorf S, Brauchlin AE, Frank M, Wilhelm MJ, Saleh L, Riener R, Schmied CM, Falk V. Robot-assisted training for heart failure patients - a small pilot study. Acta Cardiol. 2015 Dec;70(6):665-71. doi: 10.2143/AC.70.6.3120178.

  • Schoenrath F, Markendorf S, Brauchlin AE, Seifert B, Wilhelm MJ, Czerny M, Riener R, Falk V, Schmied CM. Robot-Assisted Training Early After Cardiac Surgery. J Card Surg. 2015 Jul;30(7):574-80. doi: 10.1111/jocs.12576. Epub 2015 May 22.

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Volkmar Falk, MD

    University of Zurich

    STUDY DIRECTOR

Central Study Contacts

Felix Schoenrath, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2014

First Posted

May 23, 2014

Study Start

February 1, 2014

Primary Completion

November 1, 2014

Study Completion

December 1, 2014

Last Updated

October 30, 2014

Record last verified: 2014-10

Locations